Centro Integral Oncologico Clara Campal - Unidad de Fase I-Oncologica

Madrid 28050

0 studies enrolling now · 4 studies all time

What they study most

Advanced Solid Tumor, Gastric Cancer, Metastatic or Locally Advanced Unresectable Solid Tumors, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Solid Tumors

Studies at this site

• Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) — Running, not enrolling
• M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) — Running, not enrolling
• Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320) — Running, not enrolling
• Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301) — Running, not enrolling